Company Filing History:
Years Active: 2023
Title: David Kent - Innovator in Ocular Drug Delivery
Introduction
David Kent is a notable inventor based in Waterford, Ireland. He has made significant contributions to the field of ocular drug delivery through his innovative work. His research focuses on enhancing the effectiveness of therapeutic agents for eye disorders.
Latest Patents
David Kent holds a patent for an invention titled "Ocular Drug Delivery." This invention relates to a Nanostructured Lipid Carrier (NLC) particle that comprises a therapeutic agent encapsulated for ocular delivery. The NLC particle features a solid outer shell made of solid lipid and a liquid core containing a liquid lipid, which houses the therapeutic agent. The patent also covers compositions of the NLC particles, their uses, methods for treating or preventing eye disorders, and an eye drop dispenser.
Career Highlights
David Kent is affiliated with the Waterford Institute of Technology, where he continues to advance his research in ocular drug delivery. His work has the potential to significantly improve treatment options for patients suffering from various eye conditions.
Collaborations
David collaborates with talented individuals such as Gautam Behl and Sangeeta Kumari, who contribute to his research efforts and innovations.
Conclusion
David Kent's work in ocular drug delivery exemplifies the impact of innovative thinking in the medical field. His patent for the Nanostructured Lipid Carrier represents a significant advancement in the delivery of therapeutic agents for eye disorders.